Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

出版年份 2020 全文链接

标题

作者

关键词

COVID-19, Cytokine release syndrome, Tocilizumab, IL-6, IL-6R

出版物

Volume 55, Issue 5, Pages 105954

出版商

Elsevier BV

发表日期

2020-03-29

DOI

10.1016/j.ijantimicag.2020.105954

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started